# OnCo record kim-dong-wan (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/kim-dong-wan/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "kim-dong-wan" ;
  schema:name "Dong-Wan Kim"@en ;
  schema:description "Dong-Wan Kim is a thoracic oncologist central to the ALK and ROS1 inhibitor trials, from crizotinib to brigatinib and beyond."@en ;
  schema:url <https://onco.cc/people/kim-dong-wan/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.snuh.org>, <https://pubmed.ncbi.nlm.nih.gov/?term=Kim%20DW%5BAuthor%5D%20Seoul%20National%20University%20ALK%20lung> ;
  schema:jobTitle "Professor of Internal Medicine; thoracic oncology" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/alk/>, <https://onco.cc/targets/ros1/> ;
  onco:drugs <https://onco.cc/drugs/lorlatinib/>, <https://onco.cc/drugs/repotrectinib/> ;
  onco:institutions <https://onco.cc/institutions/snuh/> ;
  schema:affiliation <https://onco.cc/institutions/snuh/> .